162 related articles for article (PubMed ID: 36127398)
21. ARHGAP18, a GTPase-activating protein for RhoA, controls cell shape, spreading, and motility.
Maeda M; Hasegawa H; Hyodo T; Ito S; Asano E; Yuang H; Funasaka K; Shimokata K; Hasegawa Y; Hamaguchi M; Senga T
Mol Biol Cell; 2011 Oct; 22(20):3840-52. PubMed ID: 21865595
[TBL] [Abstract][Full Text] [Related]
22. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin.
Bruewer M; Hopkins AM; Hobert ME; Nusrat A; Madara JL
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C327-35. PubMed ID: 15044152
[TBL] [Abstract][Full Text] [Related]
23. DGC-specific
Nishizawa T; Nakano K; Harada A; Kakiuchi M; Funahashi SI; Suzuki M; Ishikawa S; Aburatani H
Oncotarget; 2018 May; 9(33):23198-23207. PubMed ID: 29796182
[No Abstract] [Full Text] [Related]
24. Regulation of phospholipase C-delta1 by ARGHAP6, a GTPase-activating protein for RhoA: possible role for enhanced activity of phospholipase C in hypertension.
Ochocka AM; Grden M; Sakowicz-Burkiewicz M; Szutowicz A; Pawelczyk T
Int J Biochem Cell Biol; 2008; 40(10):2264-73. PubMed ID: 18434237
[TBL] [Abstract][Full Text] [Related]
25. Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells.
Papadopoulou N; Charalampopoulos I; Alevizopoulos K; Gravanis A; Stournaras C
Exp Cell Res; 2008 Oct; 314(17):3162-74. PubMed ID: 18694745
[TBL] [Abstract][Full Text] [Related]
26. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
[TBL] [Abstract][Full Text] [Related]
27. Feedback regulation through myosin II confers robustness on RhoA signalling at E-cadherin junctions.
Priya R; Gomez GA; Budnar S; Verma S; Cox HL; Hamilton NA; Yap AS
Nat Cell Biol; 2015 Oct; 17(10):1282-93. PubMed ID: 26368311
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
Xu XT; Song QB; Yao Y; Ruan P; Tao ZZ
Hepatogastroenterology; 2012; 59(120):2523-6. PubMed ID: 22584506
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
Korourian A; Roudi R; Shariftabrizi A; Madjd Z
Exp Biol Med (Maywood); 2017 Dec; 242(18):1842-1847. PubMed ID: 28836853
[TBL] [Abstract][Full Text] [Related]
30. Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function.
Gimond C; van Der Flier A; van Delft S; Brakebusch C; Kuikman I; Collard JG; Fässler R; Sonnenberg A
J Cell Biol; 1999 Dec; 147(6):1325-40. PubMed ID: 10601344
[TBL] [Abstract][Full Text] [Related]
31. Rho GTPases and the downstream effectors actin-related protein 2/3 (Arp2/3) complex and myosin II induce membrane fusion at self-contacts.
Sumida GM; Yamada S
J Biol Chem; 2015 Feb; 290(6):3238-47. PubMed ID: 25527498
[TBL] [Abstract][Full Text] [Related]
32. Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis.
Cai J; Niu X; Chen Y; Hu Q; Shi G; Wu H; Wang J; Yi J
Neoplasia; 2008 Jan; 10(1):41-51. PubMed ID: 18231637
[TBL] [Abstract][Full Text] [Related]
33. Lung endothelial barrier disruption in Lyl1-deficient mice.
Pirot N; Delpech H; Deleuze V; Dohet C; Courtade-Saïdi M; Basset-Léobon C; Chalhoub E; Mathieu D; Pinet V
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L775-85. PubMed ID: 24532287
[TBL] [Abstract][Full Text] [Related]
34. Regulated recruitment of SRGAP1 modulates RhoA signaling for contractility during epithelial junction maturation.
Liang X; Kiru S; Gomez GA; Yap AS
Cytoskeleton (Hoboken); 2018 Feb; 75(2):61-69. PubMed ID: 29160905
[TBL] [Abstract][Full Text] [Related]
35. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
36. In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS.
Krall R; Sun J; Pederson KJ; Barbieri JT
Infect Immun; 2002 Jan; 70(1):360-7. PubMed ID: 11748202
[TBL] [Abstract][Full Text] [Related]
37. The Significance of the
Zhang WH; Zhang SY; Hou QQ; Qin Y; Chen XZ; Zhou ZG; Shu Y; Xu H; Hu JK
Front Oncol; 2020; 10():1214. PubMed ID: 32983960
[No Abstract] [Full Text] [Related]
38. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
Eitaki M; Yamamori T; Meike S; Yasui H; Inanami O
BMC Cancer; 2012 Oct; 12():469. PubMed ID: 23057787
[TBL] [Abstract][Full Text] [Related]
39. FilGAP and its close relatives: a mediator of Rho-Rac antagonism that regulates cell morphology and migration.
Nakamura F
Biochem J; 2013 Jul; 453(1):17-25. PubMed ID: 23763313
[TBL] [Abstract][Full Text] [Related]
40. N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition.
Pagano C; Navarra G; Pastorino O; Avilia G; Coppola L; Della Monica R; Chiariotti L; Florio T; Corsaro A; Torelli G; Caiazzo P; Gazzerro P; Bifulco M; Laezza C
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
